Mr. Pyszczymuka is a proven commercial leader with extensive experience in pharmaceutical sales, market access, and revenue growth. He currently serves as Chief Commercial Officer at Aytu BioPharma, a ...

Search for a state or federal candidate to see the donors and industries that support them.

OpenSecrets is 100% funded through the generosity of donors.

Merck & Co. Inc. 0.87% $235.4B ...

Endo's slide into bankruptcy follows in the footsteps of Purdue Pharma – which filed in 2019 but is still negotiating opioid settlement and corporate restructuring terms – as well as ...

For more information, ask your healthcare provider or pharmacist. Endo is a diversified specialty pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate ...

Infinity Pharmaceuticals Inc. 0.00% $90.76 ...

After hours: February 28 at 7:24:59 PM EST Loading Chart for CRNX ...

After hours: March 3 at 4:05:06 PM EST Loading Chart for XENE ...

JPMorgan upgraded Amneal Pharmaceuticals (AMRX) to Overweight from Neutral with a price target of $12, up from $9. The firm cites the Crexont launch being off to a solid start and continued ...